Vascular Access Device Market Report 2026-2031, By Type, Application, and Geo

Vascular Access Device Market Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031

$6.29B

MARKET SIZE, 2026

$8.70B

MARKET SIZE, 2031

6.7%

CAGR (2026-2031)

2026-2031

FORECAST PERIOD

VASCULAR ACCESS DEVICE MARKET SIZE, SHARE & GROWTH SNAPSHOT

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global vascular access device market is projected to grow from USD 6.29 billion in 2026 to USD 8.70 billion by 2031, at a CAGR of 6.7% during the forecast period. The market was valued at USD 5.94 billion in 2025. Market growth is predominantly driven by the rising prevalence of chronic and lifestyle diseases such as cancer, diabetes, cardiovascular disorders, and kidney failure, which require frequent or long-term intravenous treatment. Increasing surgical volumes, hospital admissions, and emergency and critical-care needs, together with a strong emphasis on infection prevention, are accelerating the adoption of safety-engineered, antimicrobial-coated, and ultrasound-guided access solutions across hospital, ambulatory, and home-care settings.

KEY TAKEAWAYS

MARKET SNAPSHOT:
Base Year Market Size (2025): USD 5.94 Billion
Current Market Size (2026): USD 6.29 Billion
Forecast Market Size (2031): USD 8.70 Billion
CAGR (2026�2031): 6.7%
SEGMENT LEADERSHIP:
Product Leader: Peripheral vascular access devices are expected to register the highest CAGR of 7.5% during the forecast period.
Route of Insertion Leader: Subcutaneous route of insertion is expected to grow at the highest CAGR of 7.7%.
Application Leader: Drug administration accounted for the largest market share of 46.7% in 2025.
End User Leader: Hospitals held the largest share of the vascular access device market, accounting for 51.8% in 2025.
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Becton Dickinson, Teleflex, and Terumo Corporation are among the major players in the vascular access device market, offering comprehensive portfolios spanning peripheral, central, and intraosseous access with a focus on infection prevention, safety-engineered designs, and ultrasound-guided placement.
Companies such as Guangdong Baihe Medical Technology (China), Medi-tech Medical Devices (India), and Delta Med (Italy) are emerging players specializing in differentiated catheter designs and targeted clinical applications.

Rising chronic disease burden, expanding chemotherapy and dialysis volumes, and stringent infection-prevention standards are prompting healthcare providers to upgrade their vascular access programs. Manufacturers are emphasizing next-generation safety-engineered designs, antimicrobial and antithrombogenic coatings, ultrasound-guided insertion, and integrated all-in-one insertion systems. As infusion therapy shifts toward outpatient and home-care settings, demand for reliable, infection-resistant, and easy-to-place devices is expected to rise steadily.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The figure highlights how the vascular access device market is maturing from conventional catheters and manual, landmark-based insertion toward safer, image-guided, and infection-resistant access systems. Earlier device generations focused primarily on basic fluid and drug delivery. Newer platforms increasingly offer safety-engineered passive mechanisms, antimicrobial and antithrombogenic coatings, ultrasound-guided placement, longer-dwell midline and PICC designs, and integrated all-in-one insertion systems. Supported by smart infusion technologies and data-driven protocols, these capabilities help providers reduce catheter-related bloodstream infections and needlestick injuries, extend device dwell times, and standardize vascular access management across hospital, ambulatory, and home-care settings.

vascular-access-device-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Rising global prevalence of chronic and lifestyle-related diseases
Rapid growth in the geriatric population and associated vascular disease burden

RESTRAINTS

Impact
Level

High costs of vascular access device placement and maintenance
Rising product failures and device recalls

OPPORTUNITIES

Impact
Level

Technological innovation in vascular access devices
Expanding product approvals and regulatory momentum

CHALLENGES

Impact
Level

Clinical complications associated with vascular access devices
Shortage of skilled professionals for vascular access device placement and management

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising global prevalence of chronic and lifestyle-related diseases

The global rise in lifestyle-related and chronic diseases—including diabetes, obesity, cancer, cardiovascular disease, and kidney failure—is sharply increasing the number of patients who require short- and long-term vascular access for drug administration, chemotherapy, dialysis, and blood transfusion. The International Diabetes Federation (IDF) estimates the global adult diabetes population reached approximately 590 million in 2025, while aging populations further expand the at-risk pool, sustaining strong demand for reliable vascular access devices.

Restraint: Rising product failures and device recalls

The market faces pressure from rising product recalls and failures, driven by strict regulatory scrutiny from agencies such as the FDA and CDSCO. Because vascular access devices are in direct contact with blood, malfunctions can cause serious complications such as infection, thrombosis, and, in severe cases, death. Recalls across multiple regions have adversely affected market growth and the manufacturer's reputation.

Opportunity: Technological innovation in vascular access devices

Advances in placement and imaging—particularly non-invasive, widely available ultrasound—have made it one of the best visualization methods for vascular access. Cost-effective, high-efficiency image-guided access enables accurate assessment of vein suitability and early detection of complications, improving procedural precision and patient outcomes and expanding the pool of patients who can be safely cannulated.

Challenge: Shortage of skilled professionals for vascular access device placement and management

A global shortage of clinicians skilled in vascular access—including nurses, physicians, and specialists—constrains market growth. Incorrect device placement can cause serious harm, such as vessel damage, bleeding, air embolism, pneumothorax, and bloodstream infection. Rising demand for complex procedures and limited training in emerging markets compounds the challenge, making it harder for some regions to keep pace with new technologies.

VASCULAR ACCESS DEVICE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Portfolio spans closed PIVC systems (BD Nexiva) and ultrasound-guided midlines (BD PowerGlide Pro) for extended peripheral therapy and streamlined insertion workflows	Closed, integrated design supports longer dwell and reduced blood exposure and needlestick risk, while midlines allow dwell of up to 29 days with guidewire-assisted placement to improve insertion success
	Emergency intraosseous access (Arrow EZ-IO) and antimicrobial-impregnated short-term CVCs (Arrowg+ard Blue Plus) covering difficult-access and high infection-risk patients	IO enables access in about 10 seconds with high first-attempt success, while chlorhexidine/silver-sulfadiazine CVCs suppress microbial colonization and reduce catheter-related bloodstream infections
	Subcutaneous infusion systems (Terufusion®), infusion sets, safety needles, and drug delivery devices designed to support continuous subcutaneous administration of biologics, insulin, analgesics, and other specialty therapies across hospital and home care settings	Precision-engineered infusion systems provide consistent drug delivery, low dead-space design, secure needle fixation, and enhanced patient comfort, supporting reliable long-term subcutaneous therapy while minimizing leakage, dislodgement, and infusion-related complications
	Antimicrobial hemodialysis catheter caps (ClearGuard HD) standardize line access and protect catheter hubs	A straight fluid path minimizes reflux and occlusion and provides a microbial barrier, while ClearGuard HD caps achieved significant CLABSI reductions in multicenter randomized trials
	Subcutaneous infusion systems (Introcan Safety 2 SC), winged infusion sets (Saf-T-Intima), and infusion accessories designed for continuous and intermittent subcutaneous administration of medications, fluids, and biologic therapies in hospital and home care settings	Soft cannula technology improves patient comfort and reduces tissue trauma, while integrated safety features and secure fixation help minimize needlestick injuries, accidental dislodgement, and leakage, supporting reliable long-term subcutaneous infusion and consistent clinical workflows

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The vascular access device ecosystem consists of device manufacturers, raw-material and component suppliers, regulatory authorities, distributors, and group purchasing organizations (GPOs), and end users such as hospitals, clinics, and ambulatory care centers. Manufacturers increasingly focus on infection-prevention technologies, safety-engineered designs, ultrasound-guided placement, and integrated insertion systems, while regulatory bodies and infection-control standards shape product requirements and adoption.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

VAD Market, By Type

Central vascular access devices hold a leading share given their critical role in long-term, high-acuity therapy—chemotherapy, parenteral nutrition, and hemodialysis—while peripheral devices are the fastest-growing type, supported by rising hospital admissions, outpatient procedures, and safety-engineered short-term access.

VAD Market, By Route of Insertion

The subcutaneous route accounts for the largest and fastest-growing share, driven by the increasing adoption of biologics, immunotherapies, and self-administered treatments that require convenient, minimally invasive, and reliable drug delivery across chronic care, home healthcare, and outpatient settings.

VAD Market, By Application

The drug administration segment holds the largest share, reflecting the central role of vascular access in delivering antibiotics, chemotherapy, biologics, and critical-care infusions, reinforced by growth in outpatient and home infusion therapy.

VAD Market, By End User

Hospitals account for the largest share due to high procedure volumes and the availability of trained clinicians and imaging for safe insertion, while clinics and ambulatory care centers are the fastest-growing end users as outpatient care expands.

VAD Market, By Region

North America leads on the strength of chronic disease prevalence, advanced infrastructure, and premium device adoption, while Asia Pacific grows fastest, supported by expanding hospital networks and rising healthcare investment.

REGION

Asia Pacific to register the highest growth during the forecast period

Asia Pacific is the fastest-growing vascular access device market because of the rising chronic disease burden, expanding healthcare infrastructure, increasing surgical and hospitalization rates, growing oncology and dialysis populations, higher healthcare spending, and wider adoption of advanced vascular access devices supported by government healthcare initiatives.

VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX

In the vascular access device market matrix, Becton Dickinson (Star) leads through an extensive peripheral and central access portfolio, broad global presence, and strong GPO relationships, reinforced by its entry into the central-line segment with the BD CentroVena One Insertion System. Access Vascular (Emerging Leader) is strengthening its position with differentiated, biomaterial-based catheter technologies designed to reduce thrombosis and infection, addressing evolving clinical and patient-safety requirements.

vascular-access-device-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Becton, Dickinson and Company (US)
Terumo Corporation (Japan)
Teleflex Incorporated (US)
ICU Medical, Inc. (US)
B. Braun SE (Germany)
Merit Medical Systems ,Inc. (US)
Nipro Corporation (Japan)
Vygon (France)
AngioDynamics, Inc. (US)
Mozarc Meidcal Holdings LLC (US)
Spectrum Vascular (US)
AMECATH (Egypt)
Medical Components, Inc. (Medcomp) (US)
Healthline Medical Products (US)
Access Vascular, Inc. (US)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 5.94 Billion
Market Forecast in 2026 (Value)	USD 6.29 Billion
Market Forecast in 2031 (Value)	USD 8.70 Billion
Growth Rate	CAGR of 6.7% from 2026–2031
Years Considered	2024–2031
Base Year	2025
Forecast Period	2026–2031
Units Considered	Value (USD Billion)/Volume (Thousand/Million Units)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Type: Central VADs Peripheral VADs Intraosseous VADs Accessories By Route of Insertion: Intravenous Subcutaneous Intraosseous By Application: Drug Administration Fluid & Nutrition Administration Blood Transfusion Diagnostics & Testing By End User: Hospitals Clinics & Ambulatory Care Centers Other End Users
Regions Covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America

WHAT IS IN IT FOR YOU: VASCULAR ACCESS DEVICE MARKET REPORT CONTENT GUIDE

vascular-access-device-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Leading Medical Device Manufacturer (US)	Product Analysis: Comparison of vascular access device types (peripheral, central, intraosseous) across infection-prevention features, dwell time, insertion workflow, and clinical application coverage.	Clear benchmarking of device strengths across safety, infection resistance, dwell performance, and procedural efficiency to support strategic portfolio and positioning decisions
Leading Hospital Network (EU)	Company Information: Detailed profiling and evaluation of additional VAD vendors (up to 5) across device types, routes of insertion, applications, and end users such as hospitals and ambulatory care centers.	Comprehensive assessment of product maturity, clinical specialization, and regional coverage to identify supply and partnership opportunities and support procurement and standardization strategies

RECENT DEVELOPMENTS

April 2026 : Becton, Dickinson and Company (BD) launched the BD CentroVena One Insertion System, described as the first all-in-one central venous catheter (CVC) insertion device on the market. It consolidates the introducer needle, syringe, guidewire, and catheter into a single device, received FDA 510(k) clearance, and entered the FDA Safer Technologies Program, marking BD's entry into the central-line segment.
October 2025 : B. Braun expanded its vascular access portfolio with a next-generation central venous catheter featuring advanced antithrombogenic and antimicrobial coatings, designed to reduce catheter-related bloodstream infections (CRBSIs) in high-risk patients, including those in intensive care and oncology.
July 2025 : Teleflex completed its acquisition of BIOTRONIK's Vascular Intervention business, expanding its vascular portfolio into drug-coated balloon catheters and stents and strengthening its presence in interventional vascular care.
June 2025 : BD introduced a new peripheral IV catheter platform incorporating antimicrobial technology and improved securement features, aimed at reducing catheter-related bloodstream infections and extending device dwell time in hospitals and clinics.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

RESEARCH METHODOLOGY

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Unlock growth potential with cutting-edge vascular access technologies amidst rising healthcare demands and challenges.

5.1

INTRODUCTION

5.2

MARKET DYNAMICS

5.2.1

DRIVERS

5.2.1.1

GROWING PREVALENCE OF LIFESTYLE DISEASES

5.2.1.2

INCREASING POPULARITY OF CHEMOTHERAPY PROCEDURES AMONG CANCER PATIENTS

5.2.1.3

RISING USE OF VASCULAR ACCESS DEVICES AMONG PEDIATRIC PATIENTS

5.2.2

RESTRAINTS

5.2.2.1

HIGH COST OF INSTALLATION AND MAINTENANCE OF VASCULAR ACCESS DEVICES

5.2.2.2

RISING PRODUCT RECALLS AND FAILURES

5.2.3

OPPORTUNITIES

5.2.3.1

TECHNOLOGICAL ADVANCEMENTS

5.2.3.2

INCREASING NUMBER OF HOSPITALS AND EXPANDING PATIENT POOL

5.2.4

CHALLENGES

5.2.4.1

SHORTAGE OF SKILLED HEALTHCARE PROFESSIONALS

5.2.4.2

RISKS ASSOCIATED WITH USE OF VASCULAR ACCESS DEVICES

5.3

TECHNOLOGY ANALYSIS

5.3.1

KEY TECHNOLOGIES

5.3.1.1

IMAGING AND NAVIGATION TECHNOLOGIES

5.3.1.2

CATHETER SECUREMENT AND STABILIZATION TECHNOLOGIES

5.3.2

COMPLEMENTARY TECHNOLOGIES

5.3.2.1

AI AND ML

5.3.3

ADJACENT TECHNOLOGIES

5.3.3.1

INFECTION CONTROL TECHNOLOGIES

5.4

INDUSTRY TRENDS

5.4.1

MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES

5.4.2

INNOVATIONS IN CATHETER MATERIALS AND COATINGS

5.5

VALUE CHAIN ANALYSIS

5.6

ECOSYSTEM ANALYSIS

5.6.1

ROLE IN ECOSYSTEM

5.7

SUPPLY CHAIN ANALYSIS

5.8

TRADE ANALYSIS

5.8.1

IMPORT DATA FOR HS CODE 901839

5.8.2

EXPORT DATA FOR HS CODE 901839

5.9

PORTER’S FIVE FORCES ANALYSIS

5.9.1

THREAT OF NEW ENTRANTS

5.9.2

THREAT OF SUBSTITUTES

5.9.3

BARGAINING POWER OF BUYERS

5.9.4

BARGAINING POWER OF SUPPLIERS

5.9.5

INTENSITY OF COMPETITIVE RIVALRY

5.10

KEY STAKEHOLDERS & BUYING CRITERIA

5.10.1

KEY STAKEHOLDERS IN BUYING PROCESS

5.10.2

KEY BUYING CRITERIA

5.11

REGULATORY ANALYSIS

5.11.1

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.11.2

REGULATORY FRAMEWORK

5.11.2.1

NORTH AMERICA

5.11.2.2

EUROPE

5.11.2.3

ASIA PACIFIC

5.11.2.4

LATIN AMERICA

5.11.2.5

MIDDLE EAST & AFRICA

5.12

PATENT ANALYSIS

5.12.1

INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS

5.13

PRICING ANALYSIS

5.13.1

INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023

5.13.2

INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023

5.14

KEY CONFERENCES & EVENTS, 2025–2026

5.15

ADJACENT MARKET ANALYSIS

5.15.1

VASCULAR CLOSURE DEVICES MARKET

5.16

UNMET NEEDS/END-USER EXPECTATIONS

5.17

TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS

5.18

INVESTMENT & FUNDING SCENARIO

5.19

IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET

VASCULAR ACCESS DEVICES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 40 Data Tables

104

6.1

INTRODUCTION

6.2

CENTRAL VENOUS ACCESS DEVICES

6.2.1

PERIPHERALLY INSERTED CENTRAL CATHETERS

6.2.1.1

BETTER DURABILITY AND INCREASED CLINICAL UTILITY FOR EXTENDED TREATMENT PLANS TO DRIVE SEGMENT

6.2.2

TUNNELED CATHETERS

6.2.2.1

LOWER RISK OF INFECTION AND SUPERIOR LONGEVITY TO SUPPORT SEGMENT GROWTH

6.2.3

NON-TUNNELED CATHETERS

6.2.3.1

NON-TUNNELED CATHETERS TO BE USED IN CRITICAL CASES WITH LIMITED PERIPHERAL ACCESS

6.2.4

IMPLANTABLE PORTS

6.2.4.1

IMPLANTABLE CONVENTIONAL PORTS

6.2.4.2

IMPLANTABLE POWER INJECTABLE PORTS

6.3

PERIPHERAL VASCULAR ACCESS DEVICES

6.3.1

PERIPHERAL VENOUS ACCESS DEVICES

6.3.1.1

PERIPHERAL INTRAVENOUS CATHETERS

6.3.1.2

MIDLINE CATHETERS

6.3.1.3

BUTTERFLY/WINGED STEEL NEEDLES

6.3.2

PERIPHERAL ARTERIAL ACCESS DEVICES

6.3.2.1

CRITICAL ROLE IN CONTINUOUS HEMODYNAMIC MONITORING AND BLOOD SAMPLING IN ACUTE CARE SETTINGS TO PROPEL SEGMENT GROWTH

6.4

ACCESSORIES

6.4.1

NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET

6.5

INTRAOSSEOUS VASCULAR ACCESS DEVICES

6.5.1

CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES

VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables

140

7.1

INTRODUCTION

7.2

INTRAVENOUS ROUTE OF INSERTION

7.2.1

RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH

7.3

SUBCUTANEOUS ROUTE OF INSERTION

7.3.1

REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH

7.4

INTRAOSSEOUS ROUTE OF INSERTION

7.4.1

NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE

VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 16 Data Tables

148

8.1

INTRODUCTION

8.2

DRUG ADMINISTRATION

8.2.1

CHEMOTHERAPY

8.2.1.1

INCREASED INCIDENCE OF CANCER AND ADVANCEMENTS IN ONCOLOGY CARE TO DRIVE SEGMENT

8.2.2

OTHER DRUG ADMINISTRATION

8.3

FLUID & NUTRITION ADMINISTRATION

8.3.1

INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH

8.4

BLOOD TRANSFUSION

8.4.1

FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH

8.5

DIAGNOSTICS & TESTING

8.5.1

INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH

VASCULAR ACCESS DEVICES MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables

163

9.1

INTRODUCTION

9.2

HOSPITALS

9.2.1

PUBLIC HOSPITALS

9.2.1.1

INCREASING DEMAND FOR AFFORDABLE HEALTHCARE SERVICES IN EMERGING ECONOMIES TO DRIVE SEGMENT

9.2.2

PRIVATE HOSPITALS

9.2.2.1

RISING DEMAND FOR ADVANCED HEALTHCARE SERVICES AND HIGH-QUALITY TREATMENT OPTIONS TO DRIVE MARKET

9.3

CLINICS & AMBULATORY CARE CENTERS

9.3.1

INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH

9.4

OTHER END USERS

VASCULAR ACCESS DEVICES MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 508 Data Tables.

174

10.1

INTRODUCTION

10.2

NORTH AMERICA

10.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

10.2.2

10.2.2.1

US TO DOMINATE NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET DURING FORECAST PERIOD

10.2.3

CANADA

10.2.3.1

RISING CANCER PREVALENCE AND ADVANCED RESEARCH INITIATIVES TO PROPEL MARKET GROWTH

10.3

EUROPE

10.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

10.3.2

GERMANY

10.3.2.1

RISING OBESITY RATES AND GROWING GERIATRIC POPULATION TO AUGMENT MARKET GROWTH

10.3.3

10.3.3.1

INCREASED DISEASE BURDEN TO FUEL UPTAKE FOR ADVANCED VASCULAR ACCESS DEVICES FOR BETTER TREATMENT PROCEDURES

10.3.4

FRANCE

10.3.4.1

PRESENCE OF VASCULAR ACCESS DEVICE MANUFACTURERS AND TECHNOLOGICAL ADVANCEMENTS TO FUEL MARKET GROWTH

10.3.5

ITALY

10.3.5.1

STRONG GOVERNMENT HEALTHCARE POLICIES TO BOOST MARKET GROWTH

10.3.6

SPAIN

10.3.6.1

GROWING GERIATRIC POPULATION AND RISING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH

10.3.7

REST OF EUROPE

10.4

ASIA PACIFIC

10.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

10.4.2

CHINA

10.4.2.1

ADVANCED HEALTHCARE INFRASTRUCTURE AND HIGH GERIATRIC POPULATION TO SUPPORT MARKET GROWTH

10.4.3

INDIA

10.4.3.1

RISING GOVERNMENTAL HEALTH EXPENDITURE AND INCREASING INCIDENCE OF CHRONIC DISEASES TO FUEL MARKET GROWTH

10.4.4

JAPAN

10.4.4.1

INCREASED GERIATRIC POPULATION AND HIGH PREVALENCE OF CANCER TO DRIVE MARKET

10.4.5

AUSTRALIA

10.4.5.1

INCREASED DEMAND FOR HEMODIALYSIS AND ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH

10.4.6

SOUTH KOREA

10.4.6.1

RISING BURDEN OF CHRONIC DISEASES AND INCREASING AGED POPULATION TO BOOST MARKET GROWTH

10.4.7

REST OF ASIA PACIFIC

10.5

LATIN AMERICA

10.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

10.5.2

BRAZIL

10.5.2.1

GROWING CANCER BURDEN AND RISING NEED FOR LONG-TERM TREATMENT FOR CHRONIC PATIENTS TO DRIVE MARKET

10.5.3

MEXICO

10.5.3.1

INCREASING FOCUS ON DIALYSIS FOR PATIENTS WITH CHRONIC KIDNEY DISEASES TO DRIVE ADOPTION OF ADVANCED VASCULAR ACCESS DEVICES

10.5.4

REST OF LATIN AMERICA

10.6

MIDDLE EAST & AFRICA

10.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10.6.2

GCC COUNTRIES

10.6.2.1

INCREASING HEALTHCARE INVESTMENTS AND RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH

10.6.3

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Discover leading strategies and market positions shaping the vascular access devices competitive landscape.

357

11.1

INTRODUCTION

11.2

KEY PLAYER STRATEGIES/RIGHT TO WIN

11.2.1

OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET

11.3

REVENUE ANALYSIS, 2019–2023

11.4

MARKET SHARE ANALYSIS, 2023

11.5

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023

11.5.1

STARS

11.5.2

EMERGING LEADERS

11.5.3

PERVASIVE PLAYERS

11.5.4

PARTICIPANTS

11.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2023

11.5.5.1

COMPANY FOOTPRINT

11.5.5.2

REGION FOOTPRINT

11.5.5.3

TYPE FOOTPRINT

11.5.5.4

ROUTE OF INSERTION FOOTPRINT

11.5.5.5

APPLICATION FOOTPRINT

11.5.5.6

END-USER FOOTPRINT

11.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023

11.6.1

PROGRESSIVE COMPANIES

11.6.2

RESPONSIVE COMPANIES

11.6.3

DYNAMIC COMPANIES

11.6.4

STARTING BLOCKS

11.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023

11.6.5.1

DETAILED LIST OF KEY STARTUP/SME PLAYERS

11.6.5.2

COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS

11.7

COMPANY VALUATION & FINANCIAL METRICS

11.7.1

FINANCIAL METRICS

11.7.2

COMPANY VALUATION

11.8

BRAND/PRODUCT COMPARISON

11.9

COMPETITIVE SCENARIO

11.9.1

PRODUCT LAUNCHES & APPROVALS

11.9.2

DEALS

11.9.3

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

378

12.1

KEY PLAYERS

12.1.1

BECTON, DICKINSON AND COMPANY

12.1.1.1

BUSINESS OVERVIEW

12.1.1.2

PRODUCTS OFFERED

12.1.1.3

RECENT DEVELOPMENTS

12.1.1.4

MNM VIEW

12.1.2

TELEFLEX INCORPORATED

12.1.3

ICU MEDICAL

12.1.4

NIPRO

12.1.5

ANGIODYNAMICS, INC.

12.1.6

VYGON

12.1.7

TERUMO CORPORATION

12.1.8

MEDTRONIC PLC

12.1.9

COOK

12.1.10

B. BRAUN SE

12.1.11

MERIT MEDICAL SYSTEMS, INC.

12.1.12

AMECATH

12.1.13

MEDICAL COMPONENTS, INC.

12.1.14

HEALTHLINE MEDICAL PRODUCTS

12.1.15

ACCESS VASCULAR, INC.

12.2

OTHER PLAYERS

12.2.1

ARGON MEDICAL DEVICES

12.2.2

PAKUMEDMEDICAL PRODUCTS GMBH

12.2.3

GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.

12.2.4

PFM MEDICAL GMBH

12.2.5

MEDI-TECH DEVICES PVT. LTD.

12.2.6

KIMAL

12.2.7

POLYMEDICURE

12.2.8

DELTAMED

12.2.9

NEWTECH MEDICAL DEVICES PVT. LTD.

12.2.10

SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

APPENDIX

449

13.1

DISCUSSION GUIDE

13.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

13.3

CUSTOMIZATION OPTIONS

13.4

RELATED REPORTS

13.5

AUTHOR DETAILS

LIST OF TABLES

TABLE 1

VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS

TABLE 2

STANDARD CURRENCY CONVERSION RATES

TABLE 3

VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS

TABLE 4

VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS

TABLE 5

VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM

TABLE 6

IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)

TABLE 7

EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)

TABLE 8

VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES

TABLE 9

INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS

TABLE 10

KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES

TABLE 11

NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 12

EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 13

ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 14

LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 15

MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 16

INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021–2023

TABLE 17

INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021–2023

TABLE 18

VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026

TABLE 19

VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS

TABLE 20

VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 21

VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 22

CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 23

CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 24

CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 25

CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 26

PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 27

PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 28

TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 29

TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 30

NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 31

NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 32

IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 33

IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 34

IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 35

IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 36

IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 37

IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 38

IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 39

IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 40

PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 41

PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 42

PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 43

PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 44

PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 45

PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 46

PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 47

PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 48

PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 49

PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 50

MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 51

MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 52

BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 53

BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 54

PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 55

PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 56

ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 57

ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 58

INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 59

INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 60

VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 61

VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 62

VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 63

VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 64

VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 65

VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 66

VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 67

VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 68

VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 69

VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 70

VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 71

VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 72

VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 73

VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 74

VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 75

VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 76

VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 77

VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 78

VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 79

VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 80

VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 81

VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 82

VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 83

VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 84

VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 85

VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 86

VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 87

VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 88

PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 89

PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 90

PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 91

PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 92

VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 93

VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 94

VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 95

VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 96

VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 97

VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION)

TABLE 98

VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS)

TABLE 99

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 100

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 101

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 102

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 103

NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 104

NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 105

NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 106

NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 107

NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 108

NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 109

NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 110

NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 111

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 112

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 113

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 114

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 115

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 116

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 117

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 118

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 119

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 120

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 121

US: KEY MACROINDICATORS

TABLE 122

US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 123

US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 124

US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 125

US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 126

US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 127

US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 128

US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 129

US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 130

US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 131

US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 132

US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 133

US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 134

US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 135

US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 136

US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 137

US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 138

US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 139

US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 140

US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 141

US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 142

CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024

TABLE 143

CANADA: KEY MACROINDICATORS

TABLE 144

CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 145

CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 146

CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 147

CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 148

CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 149

CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 150

CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 151

CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 152

CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 153

CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 154

CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 155

CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 156

CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 157

CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 158

CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 159

CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 160

CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 161

CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 162

CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 163

CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 164

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 165

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 166

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 167

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 168

EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 169

EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 170

EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 171

EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 172

EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 173

EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 174

EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 175

EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 176

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 177

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 178

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 179

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 180

EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 181

EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 182

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 183

EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 184

EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 185

EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 186

GERMANY: KEY MACROINDICATORS

TABLE 187

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 188

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 189

GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 190

GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 191

GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 192

GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 193

GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 194

GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 195

GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 196

GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 197

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 198

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 199

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 200

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 201

GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 202

GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 203

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 204

GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 205

GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 206

GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 207

UK: KEY MACROINDICATORS

TABLE 208

UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 209

UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 210

UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 211

UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 212

UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 213

UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 214

UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 215

UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 216

UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 217

UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 218

UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 219

UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 220

UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 221

UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 222

UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 223

UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 224

UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 225

UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 226

UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 227

UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 228

FRANCE: KEY MACROINDICATORS

TABLE 229

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 230

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 231

FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 232

FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 233

FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 234

FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 235

FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 236

FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 237

FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 238

FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 239

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 240

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 241

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 242

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 243

FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 244

FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 245

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 246

FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 247

FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 248

FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 249

ITALY: KEY MACROINDICATORS

TABLE 250

ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 251

ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 252

ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 253

ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 254

ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 255

ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 256

ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 257

ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 258

ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 259

ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 260

ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 261

ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 262

ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 263

ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 264

ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 265

ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 266

ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 267

ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 268

ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 269

ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 270

SPAIN: KEY MACROINDICATORS

TABLE 271

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 272

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 273

SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 274

SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 275

SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 276

SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 277

SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 278

SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 279

SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 280

SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 281

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 282

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 283

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 284

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 285

SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 286

SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 287

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 288

SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 289

SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 290

SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 291

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 292

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 293

REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 294

REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 295

REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 296

REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 297

REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 298

REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 299

REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 300

REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 301

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 302

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 303

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 304

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 305

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 306

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 307

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 308

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 309

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 310

REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 311

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 312

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 313

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 314

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 315

ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 316

ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 317

ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 318

ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 319

ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 320

ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 321

ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 322

ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 323

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 324

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 325

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 326

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 327

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 328

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 329

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 330

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 331

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 332

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 333

CHINA: KEY MACROINDICATORS

TABLE 334

CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 335

CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 336

CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 337

CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 338

CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 339

CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 340

CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 341

CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 342

CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 343

CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 344

CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 345

CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 346

CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 347

CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 348

CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 349

CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 350

CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 351

CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 352

CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 353

CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 354

INDIA: KEY MACROINDICATORS

TABLE 355

INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 356

INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 357

INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 358

INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 359

INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 360

INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 361

INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 362

INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 363

INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 364

INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 365

INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 366

INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 367

INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 368

INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 369

INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 370

INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 371

INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 372

INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 373

INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 374

INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 375

JAPAN: KEY MACROINDICATORS

TABLE 376

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 377

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 378

JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 379

JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 380

JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 381

JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 382

JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 383

JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 384

JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 385

JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 386

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 387

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 388

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 389

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 390

JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 391

JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 392

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 393

JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 394

JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 395

JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 396

AUSTRALIA: KEY MACROINDICATORS

TABLE 397

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 398

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 399

AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 400

AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 401

AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 402

AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 403

AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 404

AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 405

AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 406

AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 407

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 408

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 409

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 410

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 411

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 412

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 413

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 414

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 415

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 416

AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 417

SOUTH KOREA: KEY MACROINDICATORS

TABLE 418

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 419

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 420

SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 421

SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 422

SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 423

SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 424

SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 425

SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 426

SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 427

SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 428

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 429

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 430

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 431

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 432

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 433

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 434

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 435

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 436

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 437

SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 438

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 439

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 440

REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 441

REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 442

REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 443

REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 444

REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 445

REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 446

REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 447

REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 448

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 449

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 450

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 451

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 452

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 453

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 454

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 455

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 456

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 457

REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 458

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)

TABLE 459

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)

TABLE 460

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 461

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 462

LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 463

LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 464

LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 465

LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 466

LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 467

LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 468

LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 469

LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 470

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 471

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 472

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 473

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 474

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 475

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 476

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 477

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 478

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 479

LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 480

BRAZIL: KEY MACROINDICATORS

TABLE 481

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 482

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 483

BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 484

BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 485

BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 486

BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 487

BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 488

BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 489

BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 490

BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 491

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 492

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 493

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 494

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 495

BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 496

BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 497

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 498

BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 499

BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 500

BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 501

MEXICO: KEY MACROINDICATORS

TABLE 502

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 503

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 504

MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 505

MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 506

MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 507

MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 508

MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 509

MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 510

MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 511

MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 512

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 513

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 514

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 515

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 516

MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 517

MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 518

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 519

MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 520

MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 521

MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 522

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 523

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 524

REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 525

REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 526

REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 527

REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 528

REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 529

REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 530

REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 531

REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 532

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 533

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 534

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 535

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 536

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 537

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 538

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 539

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 540

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 541

REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 542

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)

TABLE 543

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)

TABLE 544

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 545

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 546

MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 547

MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 548

MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 549

MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 550

MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 551

MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 552

MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 553

MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 554

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 555

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 556

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 557

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 558

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 559

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 560

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 561

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 562

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 563

MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 564

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 565

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 566

GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 567

GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 568

GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 569

GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 570

GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 571

GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 572

GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 573

GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 574

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 575

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 576

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 577

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 578

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 579

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 580

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 581

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 582

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 583

GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 584

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 585

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 586

REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 587

REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 588

REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 589

REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 590

REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 591

REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 592

REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)

TABLE 593

REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)

TABLE 594

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)

TABLE 595

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)

TABLE 596

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)

TABLE 597

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)

TABLE 598

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)

TABLE 599

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)

TABLE 600

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)

TABLE 601

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)

TABLE 602

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)

TABLE 603

REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)

TABLE 604

OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET

TABLE 605

VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION

TABLE 606

VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT

TABLE 607

VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT

TABLE 608

VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT

TABLE 609

VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT

TABLE 610

VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT

TABLE 611

VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS

TABLE 612

VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS

TABLE 613

VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025

TABLE 614

VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025

TABLE 615

VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025

TABLE 616

BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW

TABLE 617

BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED

TABLE 618

BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025

TABLE 619

TELEFLEX INCORPORATED: COMPANY OVERVIEW

TABLE 620

TELEFLEX INCORPORATED: PRODUCTS OFFERED

TABLE 621

TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025

TABLE 622

TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025

TABLE 623

ICU MEDICAL: COMPANY OVERVIEW

TABLE 624

ICU MEDICAL: PRODUCTS OFFERED

TABLE 625

ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025

TABLE 626

NIPRO: COMPANY OVERVIEW

TABLE 627

NIPRO: PRODUCTS OFFERED

TABLE 628

ANGIODYNAMICS, INC.: COMPANY OVERVIEW

TABLE 629

ANGIODYNAMICS, INC.: PRODUCTS OFFERED

TABLE 630

ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025

TABLE 631

ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025

TABLE 632

VYGON: COMPANY OVERVIEW

TABLE 633

VYGON: PRODUCTS OFFERED

TABLE 634

TERUMO CORPORATION: COMPANY OVERVIEW

TABLE 635

TERUMO CORPORATION: PRODUCTS OFFERED

TABLE 636

MEDTRONIC PLC: COMPANY OVERVIEW

TABLE 637

MEDTRONIC PLC: PRODUCTS OFFERED

TABLE 638

COOK: COMPANY OVERVIEW

TABLE 639

COOK: PRODUCTS OFFERED

TABLE 640

B. BRAUN SE: COMPANY OVERVIEW

TABLE 641

B. BRAUN SE: PRODUCTS OFFERED

TABLE 642

B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025

TABLE 643

B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025

TABLE 644

MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW

TABLE 645

MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED

TABLE 646

MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025

TABLE 647

AMECATH: COMPANY OVERVIEW

TABLE 648

AMECATH: PRODUCTS OFFERED

TABLE 649

MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW

TABLE 650

MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED

TABLE 651

HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW

TABLE 652

HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED

TABLE 653

ACCESS VASCULAR, INC.: COMPANY OVERVIEW

TABLE 654

ACCESS VASCULAR, INC.: PRODUCTS OFFERED

TABLE 655

ARGON MEDICAL DEVICES: COMPANY OVERVIEW

TABLE 656

PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW

TABLE 657

GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW

TABLE 658

PFM MEDICAL GMBH: COMPANY OVERVIEW

TABLE 659

MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW

TABLE 660

KIMAL: COMPANY OVERVIEW

TABLE 661

POLYMEDICURE: COMPANY OVERVIEW

TABLE 662

DELTAMED: COMPANY OVERVIEW

TABLE 663

NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW

TABLE 664

SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW

LIST OF FIGURES

FIGURE 1

VASCULAR ACCESS DEVICES MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD

FIGURE 2

VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED

FIGURE 3

VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN

FIGURE 4

VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES

FIGURE 5

VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES

FIGURE 6

VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES

FIGURE 7

VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS

FIGURE 8

BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

FIGURE 9

MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS

FIGURE 10

VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH

FIGURE 11

MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS

FIGURE 12

IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET

FIGURE 13

VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS

FIGURE 14

VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION

FIGURE 15

CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD

FIGURE 16

TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030

FIGURE 17

IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD

FIGURE 18

PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD

FIGURE 19

PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD

FIGURE 20

INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030

FIGURE 21

DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT

FIGURE 22

CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD

FIGURE 23

HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD

FIGURE 24

PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD

FIGURE 25

ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES

FIGURE 26

RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET

FIGURE 27

US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023

FIGURE 28

ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

FIGURE 29

ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030

FIGURE 30

EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD

FIGURE 31

VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

FIGURE 32

VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS

FIGURE 33

VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS

FIGURE 34

VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS

FIGURE 35

VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 36

INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS

FIGURE 37

KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES

FIGURE 38

NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)

FIGURE 39

TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014−DECEMBER 2024)

FIGURE 40

TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014− DECEMBER 2024)

FIGURE 41

VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW

FIGURE 42

VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS

FIGURE 43

VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023

FIGURE 44

VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI

FIGURE 45

VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT

FIGURE 46

NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT

FIGURE 47

ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT

FIGURE 48

REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)

FIGURE 49

MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)

FIGURE 50

VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023

FIGURE 51

VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT

FIGURE 52

VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023

FIGURE 53

EV/EBITDA OF KEY VENDORS

FIGURE 54

YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS

FIGURE 55

VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS

FIGURE 56

BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 57

TELEFLEX INCORPORATED: COMPANY SNAPSHOT

FIGURE 58

ICU MEDICAL: COMPANY SNAPSHOT

FIGURE 59

NIPRO: COMPANY SNAPSHOT

FIGURE 60

ANGIODYNAMICS, INC.: COMPANY SNAPSHOT

FIGURE 61

TERUMO CORPORATION: COMPANY SNAPSHOT

FIGURE 62

MEDTRONIC PLC: COMPANY SNAPSHOT

FIGURE 63

B. BRAUN SE: COMPANY SNAPSHOT

FIGURE 64

MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT

Methodology

Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global vascular access device (VAD) market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the VAD market.

Secondary Research

In the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations of device manufacturers; regulatory filings and clearance databases; clinical literature and peer-reviewed journals; healthcare and infection-control association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. All of this information was further validated by primary sources.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report: marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the vascular access device market. Primary sources on the demand side include directors and presidents of hospitals & cardiac centers, as well as scientists/researchers from academic & research institutes. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends and dynamics.

In the market engineering process, top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was conducted throughout the market engineering process to present key information and insights throughout the report.

After the complete market engineering process—including calculations for market statistics, market breakups, market size estimates, market forecasts, and data triangulation—extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also used to identify segmentation types, industry trends, the competitive landscape among VAD market players, and key market dynamics, including drivers, restraints, opportunities, challenges, and key strategies.

Vascular Access Device Market
Size, and Share

Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down and bottom-up approaches were used to estimate and validate the size of the VAD market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size included identifying key market players through secondary research and determining their market shares in each region through both primary and secondary research. This entire procedure included the study of the annual and financial reports of the top market players, and extensive interviews were conducted with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.

All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.

Vascular Access Device Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, where applicable, to complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

Market Definition

A vascular access device (VAD) is a medical device used to gain access to a patient's bloodstream for the administration of drugs, fluids, blood products, and nutrition, as well as for blood sampling and diagnostic procedures. VADs include peripheral devices (such as peripheral intravenous catheters, midline catheters, and arterial catheters), central devices (such as peripherally inserted central catheters, centrally and non-tunneled/tunneled central venous catheters, and implantable ports), and intraosseous access systems, along with related accessories. These devices incorporate features such as safety-engineered designs, antimicrobial and antithrombogenic coatings, and compatibility with ultrasound-guided insertion to ensure safe, reliable, and repeatable vascular access across hospital, ambulatory, and home-care settings.

Key Stakeholders

Vascular access device manufacturers and suppliers
Hospitals, clinics, and ambulatory care centers
Clinicians (interventional radiologists, vascular access nurses, anesthesiologists, and intensivists)
Hospital procurement teams and group purchasing organizations (GPOs)
Infection-prevention and patient-safety professionals
Distributors, dealers, and contract manufacturers
Regulatory authorities and healthcare standards organizations
Research institutes and academic medical centers
Investors and technology partners

Report Objectives

To describe and forecast the global vascular access device market by type, route of insertion, application, end user, and region from 2026 to 2031, and to analyze the various macroeconomic and microeconomic factors that affect market growth.
To forecast the market size of five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
To analyze the subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market.
To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing market growth.
To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape of major players.
To profile key market players and comprehensively analyze their business overviews, regional presence, product offerings, business strategies, and key financials, and to illustrate the competitive landscape of the market.
To analyze competitive developments such as mergers & acquisitions, product launches, partnerships and collaborations, and research & development (R&D) activities in the market.

Available customizations:

With the provided market data, MarketsandMarkets offers customizations tailored to company-specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakup of the Rest of Asia Pacific market, by country
Further breakup of the Rest of Europe market, by country
Further breakup of the Rest of Latin America market, by country
Further breakup of the Middle East & African market, by country

Key Questions Addressed by the Report

Which are the top industry players in the global vascular access devices market?

The top market players in the global vascular access device market include The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), and Nipro (Japan)

What are some of the major drivers for this market?

Growth in the vascular access devices market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, the increasing number of chemotherapy procedures, and the growing use of vascular access devices in pediatric patients.

Which end users have been included in the global vascular access devices market?

This report contains the following end user segments:

Hospitals
Clinics & Ambulatory Care Centers
Other End Users

Which type of vascular access device is lucrative for the vascular access devices market?

The peripheral vascular access devices segment is expected to witness the highest growth rate during the forecast period.

Which region is lucrative for the vascular access device market?

The Asia Pacific market is expected to witness the highest CAGR during the forecast period.

Vascular Access Device Market Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031

VASCULAR ACCESS DEVICE MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Rising global prevalence of chronic and lifestyle-related diseases

Restraint: Rising product failures and device recalls

Opportunity: Technological innovation in vascular access devices

Challenge: Shortage of skilled professionals for vascular access device placement and management

VASCULAR ACCESS DEVICE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

VAD Market, By Type

VAD Market, By Route of Insertion

VAD Market, By Application

VAD Market, By End User

VAD Market, By Region

REGION

Asia Pacific to register the highest growth during the forecast period

VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: VASCULAR ACCESS DEVICE MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Available customizations:

Geographic Analysis

Company Information

Key Questions Addressed by the Report

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Vascular Access Device Market